Publications by authors named "John Killar"

Claim this Profile
S
Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process.
Federico Martinón-Torres, David Greenberg, Meera Varman, John A Killar, Darcy Hille

Pediatr Infect Dis J· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Roy T Steigbigel, David A Cooper, Princy N Kumar, Joseph E Eron, Mauro Schechter, John A Killar

N Engl J Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
David A Cooper, Roy T Steigbigel, Jose M Gatell, Jurgen K Rockstroh, Christine Katlama, John A Killar

N Engl J Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Johan Maertens, Axel Glasmacher, Raoul Herbrecht, Anne Thiebaut, Catherine Cordonnier, John Killar

Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
Nicholas Kartsonis, John Killar, Lori Mixson, Chao-Min Hoe, Carole Sable

Antimicrob Agents Chemother· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis